Which mechanism causes reduced palatability in chemotherapy patients?

💡 Explanation

Chemotherapy agents often cause damage to rapidly dividing cells, and thus, gustatory cellular apoptosis diminishes taste receptor cells; a decrease in taste sensitivity occurs because the cells are destroyed, therefore the patient has reduced palatability of foods, rather than other olfactory or buffering effects.

• Why does a patient with a duodenal switch bariatric surgery maintain satiety despite a reduced stomach size?
• Why does elevated FSH, despite ovulation, fail to ensure successful implantation?
• Which physiological outcome results post-implantation from placental lactogen secretion?
• If a patient consistently excretes highly concentrated urine with elevated calcium and oxalate levels, but does *not* develop kidney stones, which mechanism is most likely protecting them?
• Why does a mutated epidermal growth factor receptor (EGFR) in lung cancer cells increase the likelihood of uncontrolled proliferation, even with functional cell cycle checkpoints?
• If a patient has a genetic mutation causing dysfunctional fibrinogen, which consequence follows regarding clot formation following a deep wound?